Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00079261

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +14 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Algemeen Ziekenhuis Sint-Augustinus Wilrijk, Belgium
  • University Hospital Rebro Zagreb, Croatia
  • National Cancer Institute - Cairo Cairo, Egypt
View Trial Details
Completed

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00110045

Conditions
Adnexal Diseases, Amyloidosis, Ataxia, +137 more
Locations
  • CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium
  • Centre Hospitalier Universitaire Henri Mondor Créteil, France
  • Hopital Edouard Herriot - Lyon Lyon, France
  • Hopital Saint-Louis Paris, France
View all 13 locations
View Trial Details
Completed

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

NCT00003805

Conditions
Blast Crisis, Blood Protein Disorders, Body Temperature Changes, +69 more
Locations
  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Algemeen Ziekenhuis Middelheim Antwerp, Belgium
  • Hopital Universitaire Erasme Brussels, Belgium
View all 28 locations
View Trial Details
Completed

Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma

NCT01679860

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Spedali Civili di Brescia Brescia, Italy
  • Azienda Ospedale Vittorio Emanuele Ferrarorro S. Bambino- Università di Catania Catania, Italy
  • Ospedale San Carlo Potenza, Italy
  • Azienda Ospedaliera S. Luigi Orbassano, Torino, Italy
View all 17 locations
View Trial Details
Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations
  • Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
  • Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
  • Erlanger Health System Chattanooga, Tennessee, United States
  • Tennessee Plateau Oncology Crossville, Tennessee, United States
View Trial Details
Completed

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides

NCT00535470

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Northwestern University-Dept. of Dermatology Chicago, Illinois, United States
  • Columbia University, Dept of Dermatology New York, United States
  • NYU Medical Center Dept. of Dermatology New York, United States
View Trial Details

Related conditions